Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06263153 |
| Title | Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Yuanquan Yang |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Michigan Comprehensive Cancer Center | RECRUITING | Ann Arbor | Michigan | 48109 | United States | Details |
| Cleveland Clinic Taussig Cancer Center | RECRUITING | Cleveland | Ohio | 44195 | United States | Details |
| Ohio State University Comprehensive Cancer Center | RECRUITING | Columbus | Ohio | 43210 | United States | Details |